Skip to main content
Premium Trial:

Request an Annual Quote

DNA2.0, Blue Sky Biotech Ink Alliance

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic genomics company DNA2.0 said today that it has forged a strategic alliance agreement with the contract research organization Blue Sky Biotech to provide integrated gene synthesis and protein expression and purification services.

Menlo Park, Calif.-based DNA2.0 said that its custom gene synthesis technology enables researchers to redesign entire gene sequences in order to maximize the likelihood of high protein expression, easy genetic manipulation, and convenient protein purification.

"The alliance with DNA2.0 enhances our production capacity in molecular biology and provides access to DNA2.0's patented technologies," Blue Sky Chief Scientific Officer Norman Garceau said in a statement. "By partnering, our clients will be able to save significant time and receive high-quality solutions."

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.